Clinical Scorecard: The United States should not accept an annual toll of 72,000 overdose fatalities

At a Glance

Key Highlights

• Drug overdose deaths fell 27% from 110,000 in 2023 to about 80,000 in 2024.
• Provisional data projects a further decline to around 72,000 deaths in 2025.
• Normalization of overdose deaths risks complacency in policy and funding.
• Historical patterns show that society can become desensitized to high death tolls.
• Current technologies and programs driving overdose decline require sustained funding.

Guideline-Based Recommendations

Diagnosis

• Monitor trends in overdose deaths and substance use disorders.
• Utilize data-driven surveillance to identify at-risk populations.

Management

• Ensure access to naloxone and medications for opioid use disorder.
• Implement harm reduction strategies and community-based interventions.

Monitoring & Follow-up

• Track overdose death rates and the effectiveness of prevention programs.
• Evaluate the impact of funding cuts on overdose prevention efforts.

Risks

• Potential for increased overdose deaths if funding for prevention is reduced.
• Normalization of high death tolls may lead to decreased public and political urgency.

Patient & Prescribing Data

Individuals with substance use disorders and those at risk of overdose.

Access to treatment and harm reduction services is critical for reducing overdose fatalities.

Clinical Best Practices

• Advocate for continued funding and support for overdose prevention programs.
• Engage in community outreach to raise awareness about overdose risks and prevention.

References

• Centers for Disease Control and Prevention
• Stanford University School of Medicine